专利号:US-2023301584-A1 优先权日:2022-01-26 标 题 :Nanosensor for real-time monitoring of wound healing, manufacturing method thereof, and real-time monitoring system for wound healing using same 发明人:JANG WOO YOUNG; HWANG JANGSUN; XU CHENJIE 权利人:UNIV KOREA RES & BUS FOUND; UNIV CITY HONG KONG 摘要:The present disclosure relates to a nanosensor for real-time monitoring of wound healing, a manufacturing method thereof, and a real-time monitoring system for wound healing using the same. A nanosensor according to example embodiments includes a biomarker for detecting mRNA and a reference gene on gold nanoparticles, thereby providing an objective indicator through monitoring of wound healing, enabling monitoring of wound healing through direct monitoring using real-time fluorescence by including a fluorescent marker in a nanoflare, and enabling evaluation of a whole wound healing process in normal and patient groups (diabetes) through real-time monitoring. In addition, the nanosensor according to the example embodiments has advantages of shortening synthesis time and improving efficiency by 30% through integration of a novel synthesis method (freezing method) rather than an existing synthesis method (salt aging).
专利号:US-6333317-B1 优先权日:1997-03-28 标 题:Regulation of amyloid precursor protein (APP) expression by administration of an estrogenic compound 发明人:LEE ROBERT K K; WURTMAN RICHARD J 权利人:MASSACHUSETTS INST TECHNOLOGY 摘要:It has been discovered that lipophilic hormones that interact with cytosolic or nuclear receptors regulate APP expression and synthesis, through modification of APP mRNA stability and/or regulation of APP gene transcription and translation activities. These studies demonstrate that the treatment of brain cells with estrone or 17β-estradiol results in a reduction in the level of APP holoprotein expression, without a concomitant change in the total level of cell protein. The reduction in the level of APP holoprotein caused by estrone or 17β-estradiol is also expected to reduce the production of neurotoxic APP fragments. In as much as estrogen deficiency in postmenopausal women is associated with a higher incidence of Alzheimer's disease, this discovery opens the possibility that estrogen therapy may prevent some of the neurodegenerative and cognitive changes associated with Alzheimer's disease, aging and other disease conditions associated with such neurodegenerative and cognitive decline.
专利号:WO-2025090435-A1 优先权日:2023-10-26 标题 :Alfaxalone synthesis 发明人:LIN ANDREW JENG SHYAN; SCOTT CAMPBELL F; RANASHINGHE RANE; MCLAREN LOUISE SALLY; WEBBER JESSIE LAUREN 权利人:ZOETIS SERVICES LLC 摘要:A process for preparing and purifying alfaxalone (3α-hydroxy-5α-pregnane) from a crude mixture of 3α- and 3β-hydroxy-5α-pregnane; and subsequent purification of the 17α- and 17β-enantiomers to obtain the 17β- enantiomer (alfaxalone).
专利号:MX-2009002267-A 优先权日:2006-08-28 标题:PROCEDURE AND INTERMEDIARIES FOR THE SYNTHESIS OF DERIVATIVES AND INTERMEDIARIES OF (3-ALQUIL-5-PIPERIDIN-1-IL-3,3A-DIHIDRO-PIRAZOLO [1,5-A] PIRIMIDIN-7-IL) -AMINO.
专利号:CN-119192270-A 优先权日:2024-09-20 标题:Synthesis method of alfasin intermediate and synthesis method of alfasin
专利号:US-2006052356-A1 优先权日:2004-09-03 标 题:Pharmacological methods to modulate oxygen consumption 发明人:WARD KEVIN R; BARBEE R W; REYNOLDS PENNY; DIEGLEMANN ROBERT; KUKREJA RAKESH; SPIESS BRUCE; EVANS MELISSA; EDWARDS ERIC 权利人:WARD KEVIN R; BARBEE R W; REYNOLDS PENNY; DIEGLEMANN ROBERT; KUKREJA RAKESH; SPIESS BRUCE; EVANS MELISSA; EDWARDS ERIC 摘要:Methods of modulating oxygen consumption in tissues are provided. In particular, the methods involve the administration of agents that transiently inhibit protein synthesis. The methods are used to treat ischemia and reperfusion-related injuries by temporarily decreasing oxygen consumption needs, and/or by inhibiting inflammation that results from reperfusion.
1: Martín Bellido V, Vettorato E. Clinical review of the pharmacological and anaesthetic effects of alfaxalone in dogs. J Small Anim Pract. 2022 May;63(5):341-361. doi: 10.1111/jsap.13454. Epub 2021 Dec 10. 203(2):141-8. doi: 10.1016/j.tvjl.2014.12.011. Epub 2014 Dec 16. 58(1):30-39. doi: 10.30802/AALAS-JAALAS-18-000010. Epub 2018 Dec 20. 4: Goodwin WA, Pasloske K, Keates HL, Ranasinghe MG, Woldeyohannes S, Perkins N. Alfaxalone for total intravenous anaesthesia in horses. Vet Anaesth Analg. 2019 Mar;46(2):188-199. doi: 10.1016/j.vaa.2018.09.047. Epub 2018 Oct 28. 261(12):1-4. doi: 10.2460/javma.23.07.0406. 59(5):531-538. doi: 10.30802/AALAS-JAALAS-19-000161. Epub 2020 Aug 5. 7: Yoshizawa K, Ukai S, Kuroda J, Yamauchi T, Yamada D, Saitoh A, Iriyama S, Nishino S, Miyazaki S. Alfaxalone improved in acute stress-induced tactile hypersensitivity and anxiety-like behavior in mice. Neuropsychopharmacol Rep. 2022 Jun;42(2):213-217. doi: 10.1002/npr2.12233. Epub 2022 Feb 4.
合成参考文献
摘要:21 CFR Sections 1308.11-1308.15 参考文献:10.1016/0278-5846(95)00310-x 摘要:Akhondzadeh S, Stone TW. Maintenance of muscimol-induced long-term depression by neurosteroids. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 1996 Feb;20(2):277–89. doi: 10.1016/0278-5846(95)00310-x. 参考文献:10.1046/j.1471-4159.1996.67052212.x 摘要:Sanna E, Motzo C, Murgia A, Amato F, Deserra T, Biggio G. Expression of Native GABAA Receptors in Xenopus Oocytes Injected With Rat Brain Synaptosomes. Journal of Neurochemistry. 1996 Nov;67(5):2212–4. doi: 10.1046/j.1471-4159.1996.67052212.x. 参考文献:10.1007/bf00171057 摘要:Russ H, Friedgen B, Königs B, Schumacher C, Graefe KH, Schömig E. Pharmacokinetic and alpha 1-adrenoceptor antagonistic properties of two cyanine-type inhibitors of extraneuronal monoamine transport. Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug;354(3):268–74. doi: 10.1007/bf00171057. 参考文献:10.1007/bf00171058 摘要:Friedgen B, Wölfel R, Russ H, Schömig E, Graefe KH. The role of extraneuronal amine transport systems for the removal of extracellular catecholamines in the rabbit. Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug;354(3):275–86. doi: 10.1007/bf00171058.